C

    CME Group Inc (CME)

    Official site

    FINANCIAL SERVICES • FINANCIAL DATA & STOCK EXCHANGES • NASDAQ

    $285.50
    -0.30 (-0.10%)

    Market Cap: $102.66B

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    88%(35/40)
    Avg Surprise
    +1.87%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$2.94
    Range$2.81 - $3.15
    13 analysts
    EPS Revisions
    4
    0
    7d
    2
    11
    30d
    EPS Estimate Drift
    90d ago$2.97+1.2%
    60d ago$2.97+1.2%
    30d ago$2.96+0.9%
    7d ago$2.94+0.0%
    Current$2.94
    Revenue Consensus
    $1.7B
    Range$1.6B - $1.8B
    9 analysts
    Period ending Dec 31, 2026
    EPS Consensus$3.04
    Range$2.74 - $3.39
    15 analysts
    Revenue Consensus
    $1.7B
    Range$1.6B - $1.9B
    13 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    -$3.04---
    Sep 26EST
    -$2.94---
    Jun 26
    Reported Jul 22
    $2.99$2.91+2.75%Beat+1.0%
    Mar 26
    Reported Apr 22
    $3.36$3.37-0.30%Miss+20.0%
    Dec 25
    Reported Feb 4
    $2.77$2.74+1.09%Beat+9.9%
    Sep 25
    Reported Oct 22
    $2.68$2.63+1.90%Beat+0.0%
    Jun 25
    Reported Jul 23
    $2.96$2.92+1.37%Beat+15.6%
    Mar 25
    Reported Apr 23
    $2.80$2.81-0.36%Miss+12.0%
    Dec 24
    Reported Feb 12
    $2.52$2.45+3.05%Beat+6.3%
    Sep 24
    Reported Oct 23
    $2.68$2.65+1.13%Beat+19.1%
    Jun 24
    Reported Jul 24
    $2.56$2.53+1.19%Beat+11.3%
    Mar 24
    Reported Apr 24
    $2.50$2.45+2.04%Beat+3.3%
    Dec 23
    Reported Feb 14
    $2.37$2.28+3.95%Beat+23.4%
    Sep 23
    Reported Oct 25
    $2.25$2.22+1.35%Beat+13.6%
    Jun 23
    Reported Jul 26
    $2.30$2.19+5.02%Beat+16.8%
    Mar 23
    Reported Apr 26
    $2.42$2.38+1.68%Beat+14.7%
    Dec 22
    Reported Feb 8
    $1.92$1.88+2.13%Beat+15.7%
    Sep 22
    Reported Oct 26
    $1.98$1.94+2.06%Beat+23.7%
    Jun 22
    Reported Jul 27
    $1.97$1.93+2.07%Beat+20.1%
    Mar 22
    Reported Apr 27
    $2.11$2.00+5.50%Beat+17.9%
    Dec 21
    Reported Feb 9
    $1.66$1.64+1.22%Beat+19.4%
    Sep 21
    Reported Oct 27
    $1.60$1.55+3.23%Beat+15.9%
    Jun 21
    Reported Jul 28
    $1.64$1.61+1.86%Beat+0.6%
    Mar 21
    Reported Apr 28
    $1.79$1.76+1.70%Beat-23.2%
    Dec 20
    Reported Feb 10
    $1.39$1.36+2.21%Beat-8.6%
    Sep 20
    Reported Oct 28
    $1.38$1.44-4.17%Miss-27.4%
    Jun 20
    Reported Jul 29
    $1.63$1.64-0.61%Miss-7.4%
    Mar 20
    Reported Apr 29
    $2.33$2.21+5.43%Beat+43.8%
    Dec 19
    Reported Feb 12
    $1.52$1.55-1.94%Miss-14.1%
    Sep 19
    Reported Oct 30
    $1.90$1.75+8.57%Beat+31.0%
    Jun 19
    Reported Jul 31
    $1.76$1.76+0.00%Beat+1.1%
    Mar 19
    Reported May 1
    $1.62$1.60+1.25%Beat-12.9%
    Dec 18
    Reported Feb 14
    $1.77$1.72+2.91%Beat+58.0%
    Sep 18
    Reported Oct 25
    $1.45$1.43+1.40%Beat+21.8%
    Jun 18
    Reported Jul 26
    $1.74$1.72+1.16%Beat+41.5%
    Mar 18
    Reported Apr 26
    $1.86$1.85+0.54%Beat+52.5%
    Dec 17
    Reported Feb 1
    $1.12$1.10+1.82%Beat-1.8%
    Sep 17
    Reported Oct 26
    $1.19$1.16+2.59%Beat+13.3%
    Jun 17
    Reported Aug 1
    $1.23$1.21+1.65%Beat-
    Mar 17
    Reported Apr 27
    $1.22$1.20+1.67%Beat-
    Dec 16
    Reported Feb 2
    $1.14$1.10+3.64%Beat-
    Sep 16
    Reported Oct 27
    $1.05$1.04+0.96%Beat-

    Dividends

    Dividend Metrics

    Yield1.33%
    Annual/Share$3.80
    Payout Ratio31.81%
    Frequency4
    Pay MonthsMar, Jun, Sep, Dec

    Growth

    3Y CAGR+7.72%
    5Y CAGR+8.02%
    View CME's full dividend history

    Key Metrics

    Valuation
    P/E Ratio24.19EV/EBITDA16.75x
    Price/FCF24.44xFCF Yield4.09%
    Profitability
    Profit Margin63.40%Operating Margin65.00%
    ROE15.80%ROIC0.70%
    Financial Health
    Debt/Equity0.13xInterest Coverage1.69x
    Current Ratio1.02xQuick Ratio1.02x
    Trading Statistics
    Beta0.27Avg Volume1.86M
    52-Week High$319.8252-Week Low$218.31

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$277.40
    SMA 20$270.97
    SMA 50$254.77
    SMA 200$274.96
    EMA 10$278.34
    EMA 20$272.38
    EMA 50$265.33
    EMA 200$268.95

    MACD

    Line: 7.24Signal: 6.06Hist: 1.18

    ADX

    ADX: 28.0+DI: 30.5-DI: 12.8

    Aroon & PSAR

    Aroon Up100.0
    Aroon DownN/A
    PSAR$272.05

    Bollinger Bands

    Upper Band$287.31
    Lower Band$254.63
    %B Position1206%(Upper)
    Band Width0.94

    RSI (14-Day)

    Overbought
    71.2

    Momentum Oscillators

    Stoch %K95.0
    Stoch %D94.4
    Williams %R-6.3
    ROC (10d)6.6%
    Momentum17.62
    CCI (20d)149.0
    MFI (14d)85.6

    Volatility Measures

    ATR (14d)$5.95(2.1%)
    StdDev (20d)8.17
    Hist Vol18.5%(Low)

    Volume Flow

    VWAP$285.27
    OBV38.0M
    AD Line-2.4B
    CMF (20d)0.172

    Volume Metrics

    Avg Vol (20d)1.9M
    Vol Ratio1.6x(High)
    VWMA (20d)$271.86

    Pivot Points

    R3$294.56
    R2$290.43
    R1$288.12
    Pivot Point$283.99
    S1$281.67
    S2$277.54
    S3$275.23

    Advanced Oscillators

    TSI33.50
    Ultimate Osc71.9
    KST96.45

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$1.71B$1.88B$1.65B$1.54B$1.69B$1.64B$1.53B$1.58B$1.53B$1.49B$1.44B$1.34B
    Cost of Revenue$233.50M$223.00M$241.10M$237.60M$221.60M$206.70M$220.80M$218.80M$204.70M$206.00M$212.90M$205.50M
    Gross Profit$1.47B$1.66B$1.41B$1.30B$1.47B$1.44B$1.30B$1.37B$1.33B$1.28B$1.23B$1.13B
    Operating Expenses$365.60M$347.40M$388.00M$327.40M$341.10M$327.60M$357.40M$341.40M$327.20M$322.30M$363.20M$312.10M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$89.00M$80.70M$133.80M$91.80M$90.60M$82.80M$124.30M$93.30M$93.00M$89.70M$138.00M$88.70M
    Operating Income$1.11B$1.31B$1.02B$972.60M$1.13B$1.11B$947.10M$1.02B$1.00B$959.60M$863.20M$820.20M
    Interest Income$1.53B$1.49B$1.86B$1.65B$1.62B$980.90M$1.03B$1.11B$1.13B$1.16B$1.14B$1.35B
    Interest Expense$43.60M$43.60M$43.70M$44.00M$44.00M$41.70M$40.70M$40.20M$40.10M$39.90M$39.70M$39.60M
    Income Before Tax$1.33B$1.51B$1.58B$1.18B$1.33B$1.24B$1.10B$1.18B$1.15B$1.11B$1.01B$974.30M
    Income Tax Expense$285.90M$356.60M$395.50M$269.00M$305.20M$288.60M$222.00M$264.10M$271.30M$258.20M$191.40M$224.10M
    Net Income$1.04B$1.15B$1.18B$908.00M$1.03B$956.20M$874.60M$912.80M$883.20M$855.20M$814.60M$750.20M
    EBITDA$-71,900,000$146.10M$-160,400,000$-341,400,000$-159,700,000$388.10M$193.00M$188.10M$147.90M$80.10M$-11,700,000$-247,100,000
    EBIT$-156,100,000$62.80M$-242,800,000$-424,000,000$-243,100,000$305.60M$109.60M$104.20M$63.70M$-5,200,000$-98,000,000$-335,400,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    The Investing Lesson That Changed Everything For Me

    Kirby coffee-can case - $5,000 initial buys (≈$16k today) left untouched produced one Haloid stake worth >$800,000 in Xerox, beating the professional portfolio and highlighting value of not trading winners away Bessembinder (1926-2016) on ~26,000 U.S. stocks - majority underperformed 1-month T-bills, 4% of firms generated all net wealth above T-bills, and ~90 firms (0.3%) created over half of market wealth Phelps and Mayer on 100-baggers - hundreds of 100x winners existed, the average 100-bagger took ~26 years, so premature selling of winners forfeits the disproportionate long-term compounding Behavioral evidence - Barber and Odean show most-active retail traders underperformed by >6% annually and sold stocks later seen outperforming replacements, supporting pre-commitment tools like a never-sell list Practical application - author holds winners despite valuation (GE +50% last year, forward EPS multiple >40x); recommended actions: set never-sell core positions, size for volatility, add on weakness, accept some losers

    Unknown Author
    7/20/26
    341
    Investing Strategy
    Also mentions:
    XRX
    GE
    FIX
    AMZN
    LB

    Starting Over: The 15-Stock Dividend Portfolio My Own Rules Would Build

    TOLL+M disciplined 15-stock build: 15 holdings, average forward yield >=3%, one name per sleeve, no manager overrides Toll-road core via EPD and WMB - EPD yields ~6%, 27-year increase streak, DCF coverage >1.6x; WMB grows faster but has a 2016 cut scar Real-asset income engines: UNP (rail oligopoly), CME (exchanges), LMT (defense, payout mid-60s, long backlog), VICI and Realty Income - O has 30+ years of raises Framework fills gaps: NextEra - dividend +10% last year, payout ~40%; PepsiCo - yield >4% and 50+ years of raises; TXN and AbbVie meet TOLL+M thresholds Investor playbook: one-per-sector diversification, target >=3% avg forward yield, score holdings with TOLL+M, avoid concentration, add sleeves for higher income or themes

    Unknown Author
    7/6/26
    422
    Portfolio Construction
    Model Portfolio
    Dividend Investing
    Dividend Growth
    Also mentions:
    LB
    TPL
    EPD
    WMB
    UNP

    My Portfolio Review: High Conviction, Low Yield, Massive Upside

    I run a high-conviction, concentrated portfolio of 15 stocks built around wide-moat compounders and long-term capital appreciation over current income. The portfolio excels in quality, inflation resilience, and growth, but comes with elevated volatility due to sector concentration and cyclical exposure. Core themes include Permian landowners, logistics leaders, aerospace/defense, and “tollbooth” monopolies with strong pricing power and secular tailwinds. Going forward, I aim to improve diversification and income without selling core positions, strengthening long-term compounding while managing risk.

    Unknown Author
    4/27/26
    387
    Portfolio Construction
    Also mentions:
    LB
    TPL
    ODFL
    QXO
    CSL

    News

    Frequently Asked Questions About CME

    What is CME's current dividend yield?
    CME Group Inc (CME) has a current dividend yield of 1.33%.
    Does CME pay dividends?
    Yes, CME Group Inc pays dividends with a current yield of 1.33%.
    What is CME's P/E ratio?
    CME Group Inc has a price-to-earnings (P/E) ratio of 24.19.
    What is CME's market cap?
    CME Group Inc (CME) has a market capitalization of $102.66B with a current stock price of $285.50.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.